Navigating patients with atopic dermatitis or chronic spontaneous urticaria during the COVID-19 pandemic
A rapid spread of different strains of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to an unprecedented pandemic. Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, the medical body has encountered major obstacles concerning disease management at differe...
Main Authors: | Isabelle Haddad, Kathia Kozman, Abdul-Ghani Kibbi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Allergy |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/falgy.2022.809646/full |
Similar Items
-
Rapid, persistent, and simultaneous remission of urticaria and severe atopic dermatitis after treatment with omalizumab
by: Ester Del Duca, et al.
Published: (2018-12-01) -
Chronic urticaria in a child affected by atopic dermatitis: effective treatment with omalizumab
by: Lucia Leonardi, et al.
Published: (2018-12-01) -
The Prevalence of Atopic Dermatitis and Chronic Spontaneous Urticaria are Associated with Parental Socioeconomic Status in Adolescents in China
by: Yi Xiao, et al.
Published: (2018-12-01) -
The Role of Oxidative Stress in Atopic Dermatitis and Chronic Urticaria
by: Sabina Galiniak, et al.
Published: (2022-08-01) -
Mesenchymal stem/stromal cell therapy in atopic dermatitis and chronic urticaria: immunological and clinical viewpoints
by: Eun-Young Kim, et al.
Published: (2021-10-01)